4th Quarter - Report
WINNING STRATEGIES WASHINGTON for KALEO
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Client
Income
$30,000
Expenses
—
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report (this page) | Jan 20, 2016 | $30,000 | Replaced |
| 4th Quarter - Amendment | Nov 30, 2016 | $30,000 | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Pharmaceutical drug development, Reducing opiod overdose deaths and S. 707
| Lobbyist | Covered position, as disclosed |
|---|---|
| CARL CHIDLOW | — |
| MICHAEL A MEROLA | — |
| DONNA MULLINS | — |
| CHARLA PENN | — |
| CHELSEY PENROD HICKMAN | — |
| ROBERT ZUCKER | — |
Pharmacy PHA
Pharmaceutical drug development, Reducing opiod overdose deaths and S. 707
| Lobbyist | Covered position, as disclosed |
|---|---|
| CARL CHIDLOW | — |
| MICHAEL A MEROLA | — |
| DONNA MULLINS | — |
| CHARLA PENN | — |
| CHELSEY PENROD HICKMAN | — |
| ROBERT ZUCKER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.